K Mukhida Selected Research

Parkinson Disease (Parkinson's Disease)

8/2008	A multitarget basal ganglia dopaminergic and GABAergic transplantation strategy enhances behavioural recovery in parkinsonian rats.
1/2008	Adjunctive use of the non-ionic surfactant Poloxamer 188 improves fetal dopaminergic cell survival and reinnervation in a neural transplantation strategy for Parkinson's disease.
7/2006	Erythropoietin and GDNF enhance ventral mesencephalic fiber outgrowth and capillary proliferation following neural transplantation in a rodent model of Parkinson's disease.
5/2001	Enhancement of sensorimotor behavioral recovery in hemiparkinsonian rats with intrastriatal, intranigral, and intrasubthalamic nucleus dopaminergic transplants.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

K Mukhida Research Topics

Disease

4	Parkinson Disease (Parkinson's Disease) 08/2008 - 05/2001
1	Spinal Cord Injuries (Spinal Cord Injury) 01/2005
1	Wounds and Injuries (Trauma) 01/2005

Drug/Important Bio-Agent (IBA)

1	Surface-Active Agents (Surfactants)IBA 01/2008
1	Poloxamer (Poloxamer 407)IBA 01/2008
1	Erythropoietin FDA Link 07/2006
1	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 07/2006
1	Nucleic AcidsIBA 01/2005
1	Proteins (Proteins, Gene)FDA Link 01/2005
1	AntioxidantsIBA 01/2005

Therapy/Procedure

4	Transplantation 08/2008 - 05/2001
1	Therapeutics 01/2008
1	Drug Therapy (Chemotherapy) 01/2005